Table 1.
mFOLFOX6+Bev Regimen and SOX+Bev Regimen.
| Table 1a | ||||
| mFOLFOX6+Bev (repeated every 2 weeks) | ||||
| Rp.1 | Palonosetron | iv | 0.75 mg | 15 min |
| Dexart® injection | 6.6 mg | |||
| Sarine | 50 mL | |||
| Rp.2 | Bevacizumab | iv | 5 mg/kg | 90 min |
| Sarine | 100 mL | (after the second time 60 min→30 min) | ||
| Rp.3-1 | Leucovorin | iv | 200 mg/m2 | 120 min |
| 5% glucose solution | 250 mL | |||
| Rp.3-2 | Oxaliplatin | iv | 85 mg/m2 | 120 min (co-administration with l-levofolinate) |
| 5% glucose solution | 250 mL | |||
| Rp.4 | Fluorouracil | bolus | 400 mg/m2 | bolus |
| Sarine | 50 mL | |||
| Rp.5 | Fluorouracil | civ | 2,400 mg/m2 | 46 h |
| Sarine | total 230 mL | |||
| Table 1b | ||||
| SOX+Bev (repeated every 3 weeks) | ||||
| Rp.1 | Palonosetron | iv | 0.75 mg | 15 min |
| Dexart® injection | 6.6 mg | |||
| Sarine | 50 mL | |||
| Rp.2 | Bevacizumab | iv | 7.5 mg/kg | 90 min |
| Sarine | 100 mL | (after the second time 60 min→30 min) | ||
| Rp.3 | Oxaliplatin | iv | 130 mg/m2 | 120 min |
| 5% glucose solution | 250 mL | |||
| Rp.4 | Sarine | iv | 50 mL | 15 min |
| oral cytotoxic agents | S-1 | po | 40-60 mg according to body surface area | twice daily for 2 weeks |
iv: intravenous injection, bolus: bolus injection, civ: continuous intravenous injection, po: per os